• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements

    Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements

  2. UPDATE: Updates, advisories and surprises

    UPDATE: Updates, advisories and surprises

  3. Allergan results turn up the heat on Valeant

    Allergan results turn up the heat on Valeant

  4. Ackman rebukes Allergan over response to Valeant bid

    Ackman rebukes Allergan over response to Valeant bid

  5. Allergan Files Investor Presentation

    Allergan Files Investor Presentation

  6. Pershing Proposes Six Directors for Allergan Board

    Pershing Proposes Six Directors for Allergan Board

  7. Allergan Comments on Pershing Square’s Definitive Proxy Solicitation

    Allergan Comments on Pershing Square’s Definitive Proxy Solicitation

  8. Bausch & Lomb recalls about 850,000 tubes of eye ointment

    Bausch & Lomb recalls about 850,000 tubes of eye ointment

  9. Pershing Square Hires Credit Suisse as Banker in Allergan Campaign -- Update

    Pershing Square Hires Credit Suisse as Banker in Allergan Campaign -- Update

  10. Pershing Square Hedge Fund Ends First Half Up 25%

    Pershing Square Hedge Fund Ends First Half Up 25%

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.